Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2002

01-07-2002 | Meeting abstract

Imaging implants

Author: AJ Potterton

Published in: Breast Cancer Research | Special Issue 1/2002

Login to get access

Excerpt

Implants are used for breast augmentation and for reconstruction following surgery. Magnetic resonance imaging (MRI) is the modality of choice for evaluating such breasts with a higher sensitivity and specificity than mammography or ultrasound for detecting implant rupture and an ability to assess adjacent tissues. …
Metadata
Title
Imaging implants
Author
AJ Potterton
Publication date
01-07-2002
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2002
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr533

Other articles of this Special Issue 1/2002

Breast Cancer Research 1/2002 Go to the issue

Meeting abstract

Complications of breast core biopsy

Meeting abstract

Magnetic resonance imaging (MRI) in the assessment of patients with breast carcinoma: an audit of accuracy

Meeting abstract

Plastic surgery for patients with postmastectomy syndrome

Meeting abstract

Great, I've been let off the hook (the impact of advanced practice within the breast screening department)

Meeting abstract

Extending the screening programme: how we did it and lived to tell the tale!

Meeting abstract

Is it safe to allow general practitioners open access to breast imaging?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits